[1P-070] Evaluation of new potential mTOR inhibitors via in silico and in vitro hybrid selections

^○Shams Raef^1,2, Miyatake Hideyuki^2,3, Ito Yoshihiro^1,3 (1.Emergent Bioengineering Materials Research Team, RIKEN Center for Emergent Matter Science, 2.Department of Life Science, Graduate School of Science and Engineering, Saitama University, 3.Nano Medical Engineering Laboratory, RIKEN Cluster for Pioneering Research, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan)

キーテクノロジー：Drug discovery

mTOR、Allosteric Inhibitors、Rapamycin、Virtual Ligand Screening、Protein-Protein interaction